AMGN vs VRTX
By Alex · Tickerpine
Amgen Inc. vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | VRTX |
|---|---|---|
| Price | $416.18 | $525.73 |
| Market cap | $225.15B | $133.25B |
| P/E ratio | 25.7 | 30.9 |
| ROE | 91.47% | 23.54% |
| Profit margin | 22.95% | 35.00% |
| Revenue growth | 9.50% | 12.50% |
| Dividend yield | 2.43% | — |
| Beta | 0.41 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs VRTX in plain English
- AMGN is the bigger company — about 1.7× the market cap of VRTX.
- AMGN is cheaper on earnings (P/E 25.7 vs 30.9).
- AMGN earns a higher return on equity (91% vs 24%).
- VRTX is growing revenue faster (12% vs 10%).
- AMGN pays a dividend (2.43%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.